샘플 요청 목록

 카트 문의
시장보고서
상품코드
1782866

세계의 산모 정신건강 시장

Maternal Mental Health
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 283 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

산모 정신건강 세계 시장은 2030년까지 398억 달러에 달할 전망

2024년에 99억 달러로 추정되는 산모 정신건강 세계 시장은 분석 기간인 2024-2030년에 CAGR 26.0%로 성장하여 2030년에는 398억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 산후 우울증 적응증은 CAGR 23.6%를 기록하며 분석 기간 종료까지 94억 달러에 달할 것으로 예측됩니다. 기분부전증(Dysthymia) 질환 적응증 부문의 성장률은 분석 기간 동안 CAGR 29.2%로 추정됩니다.

미국 시장은 27억 달러로 추정, 중국은 CAGR 33.8%로 성장 예측

미국의 산모 정신건강 시장은 2024년에 27억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년 분석 기간 동안 CAGR 33.8%로 성장하여 2030년에는 96억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 21.2%와 23.2%로 예측됩니다. 유럽에서는 독일이 CAGR 21.8%로 성장할 것으로 예측됩니다.

세계의 산모 정신건강 시장 - 주요 동향과 촉진요인 정리

산모 정신건강이 드디어 주목받게 된 이유는 무엇일까?

산모 정신건강은 세계 공중보건의 중요한 요소로 빠르게 인식되고 있으며, 과거에는 눈에 띄지 않던 위치에서 헬스케어의 화두로 급부상했습니다. 산후 우울증, 주산기 불안, 임신 중 및 임신 후 기분장애에 대한 인식이 높아지면서 옹호 활동과 정책에 대한 관심이 높아지고 있습니다. 수십 년 동안 산모 정신건강 문제는 사회적 낙인, 제한된 검진 프로토콜, 통합 치료 프레임워크의 부족으로 인해 과소 진단되고 과소 치료되어 왔습니다. 오늘날, 과학적 증거와 여론이 높아지면서 산모 정신건강이 어머니뿐만 아니라 영유아의 발달, 배우자와의 관계, 가족의 행복에 큰 영향을 미친다는 사실이 밝혀지고 있습니다. 경제적 불안과 사회적 고립, 의학적 합병증과 수면 부족에 이르기까지 현대 모성애의 스트레스 요인은 새내기 엄마들의 정신적 부담을 가중시키고 있습니다. COVID-19 팬데믹은 이러한 문제를 더욱 악화시켰고, 봉쇄, 의료 서비스 이용 중단, 지원 제도의 제한으로 인해 전 세계적으로 산모의 고통이 심각하게 증가하였습니다. 이에 정부, NGO, 보건기관은 검진 프로그램, 교육 캠페인, 조기 개입 전략에 투자하고 있습니다. 여성들이 자신의 고충을 솔직하게 이야기하고 적시에 치료를 받으려는 문화도 변화하고 있으며, 산모 정신건강은 보다 광범위한 여성 건강 문제의 우선 순위로 바뀌고 있습니다.

디지털 헬스 분야의 혁신은 산모 정신건강 제공에 어떤 변화를 가져오고 있는가?

기술은 산모 정신건강 및 의료 서비스 제공 방법, 접근 방법, 규모 확대 방법을 재구성하는 데 있어 중요한 역할을 하고 있습니다. 모바일 앱, 원격 정신의료, 가상 지원 그룹과 같은 디지털 건강 플랫폼은 기존의 정신건강 서비스를 이용할 수 없는 초보 산모들의 치료 공백을 메워주고 있습니다. AI가 탑재된 정신건강 도구는 행동 변화를 모니터링하고, 위험 요인을 선별하며, 산후 및 주산기 단계에 맞는 인지행동치료(CBT) 모듈을 제공하기 위해 개발되고 있습니다. 모바일 퍼스트 접근 방식은 인프라 및 의료 인력 부족으로 인해 대면 서비스에 대한 접근이 제한되는 농촌 지역이나 의료 서비스가 부족한 지역에서 특히 효과적입니다. 웨어러블 기술과 건강 추적기 역시 수면 패턴, 스트레스 수준, 호르몬 변화(산모 정신건강의 중요한 지표)를 모니터링하는 데 도움이 되는 보조 도구로 부상하고 있습니다. 또한, 통합 산모 건강 플랫폼은 현재 산과적 추적과 동시에 정신건강 리소스를 제공하여 보다 총체적인 치료 경험을 창출하고 있습니다. 치료사 및 정신건강 전문가와의 가상 상담을 통해 낙인을 줄이고, 신생아 돌봄과 회복을 병행하는 여성들에게 신중하고 유연한 지원을 제공하고 있습니다. 이러한 기술 혁신은 조기 진단과 조기 개입을 강화할 뿐만 아니라, 정신건강 관리를 민주화하여 보다 포괄적이고 모성 특유의 정서적 상황에 대응할 수 있도록 합니다.

고용주, 보험사, 의료시스템의 역할의 진화는 시장 확대를 촉진할 것인가?

산모 정신건강 생태계는 전통적인 의료 서비스 제공자를 넘어선 이해관계자 네트워크의 확장으로 재구성되고 있습니다. 고용주들은 산모의 정신건강을 노동력의 생산성과 정착에 필수적인 요소로 인식하기 시작했으며, 직원 지원 프로그램(EAP)에 산후 정신건강 리소스를 포함하도록 장려하고 있습니다. 기업 웰니스 플랫폼은 현재 육아 상담, 마음챙김 도구, 출산 후 직장 복귀의 정서적 복잡성을 인정하는 유연한 휴가 규정을 제공하고 있습니다. 보험사들도 이에 주목하고 있으며, 일부 의료보험 제도에서는 산후 치료, 산전 진찰 시 정신건강 검진, 앱을 이용한 정신건강 앱 구독료를 환급해주고 있습니다. 한편, 의료 시스템은 표준 산전 산후 관리 경로에 정신건강 평가를 통합하고 있으며, 종종 건강 검진 시 에든버러 산후 우울증 척도(EPDS)와 같은 표준화된 도구를 사용하고 있습니다. 산부인과 의사, 조산사, 치료사, 소아과 의사로 구성된 다학제 진료팀은 정신건강 문제를 조기에 발견하고 대처하기 위한 연계 진료 모델을 구축하고 있습니다. 공중보건 노력과 기부자의 재정 지원으로, 특히 자원이 부족한 환경에서 산모 정신건강 검진에 대해 지역 보건 종사자를 교육하는 시범 프로그램이 시행되고 있습니다. 정책적 차원에서 여러 국가에서 산모의 정신건강에 관한 법률이 도입되어 보편적 인 검진을 보장하고 치료에 대한 접근성을 향상 시켰습니다. 제도적 지원이 증가함에 따라 디지털 치료제, 지원 네트워크, 문화적으로 적합한 정신건강 서비스 등 확장 가능한 솔루션에 대한 수요가 지역 전체에서 가속화되고 있습니다.

산모 정신건강 시장 확대를 촉진하는 핵심 요인은 무엇일까?

산모 정신건강 시장의 성장은 진화하는 의료 서비스 제공 모델, 사회적 규범의 변화, 기술 중심의 혁신에 뿌리를 둔 몇 가지 요인에 의해 주도되고 있습니다. 치료받지 않은 산모의 정신건강 상태가 임상적, 사회적으로 미치는 영향에 대한 인식이 높아짐에 따라, 특히 모자보건 프로그램에서 조기 검진 및 개입 프로토콜에 대한 투자가 증가하고 있습니다. 디지털 플랫폼의 확산으로 특히 기술에 능숙하고 유연하며 낙인 없는 지원 옵션을 원하는 젊은 엄마들 사이에서 돌봄에 대한 접근성이 확대되고 있습니다. 모체 형성 지연, 고위험 임신 비율 증가와 같은 인구통계학적 변화는 주산기 정서적 취약성을 증가시키는 요인으로 작용하고 있으며, 예방적 정신건강 서비스에 대한 수요를 촉진하고 있습니다. 산부인과 및 소아과 환경에서의 행동 건강의 통합이 진행됨에 따라, 임신부터 산후까지 지속적으로 정신건강을 모니터링할 수 있는 구조적 경로가 마련되고 있습니다. 보험 제도 개혁과 고용주 지원 의료 이니셔티브는 공공 및 민간 부문 모두에서 산모 정신건강 서비스 상환과 이용을 촉진하고 있습니다. 또한, 문화적으로 배려한 다국어 컨텐츠를 이용할 수 있게 됨에 따라 다양한 사람들에게 더 잘 다가갈 수 있게 되었습니다. 중저소득 국가에서는 기부자 주도의 프로그램이나 세계 보건 파트너십을 통해 풀뿌리 개입과 정신건강 훈련의 규모를 확대하여 선진국 이외의 지역으로 시장 가능성을 넓히고 있습니다. 산모 정신건강에 대한 이야기가 소극적 치료에서 적극적 웰빙으로 진화함에 따라, 전 세계적으로 서비스, 기술, 지원 생태계에 대한 지속적이고 다양한 수요가 발생하고 있습니다.

부문

질환별 적응증(산후 우울증 적응증, 기분부전증 적응증, 임신중·산후 범불안장애 적응증, 임신중·산후 강박장애 적응증, 출산 관련 PTSD 적응증, 기타 질환별 적응증), 치료법(항우울제 치료, 대인관계 요법, 인지 행동 치료, 기타 치료법)

조사 대상 기업 사례

  • Ahma & Co Postpartum Retreat
  • Anne Arundel Medical Center Maternal Mental Health
  • BetterHelp
  • COOJ Mental Health Foundation
  • Inova Perinatal Mental Health
  • Mammha
  • Maternal Mental Health Alliance
  • Maternal Mental Health Leadership Alliance
  • MPower Minds
  • MS Chellamuthu Trust & Research Foundation
  • Parivarthan Counselling, Training and Research Centre
  • Policy Center for Maternal Mental Health
  • Postpartum Support International
  • Seleni Institute
  • Tele-MANAS
  • The Live Love Laugh Foundation
  • The Motherhood Group

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.08.08

Global Maternal Mental Health Market to Reach US$39.8 Billion by 2030

The global market for Maternal Mental Health estimated at US$9.9 Billion in the year 2024, is expected to reach US$39.8 Billion by 2030, growing at a CAGR of 26.0% over the analysis period 2024-2030. Postpartum Depression Disease Indication, one of the segments analyzed in the report, is expected to record a 23.6% CAGR and reach US$9.4 Billion by the end of the analysis period. Growth in the Dysthymia Disease Indication segment is estimated at 29.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 33.8% CAGR

The Maternal Mental Health market in the U.S. is estimated at US$2.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$9.6 Billion by the year 2030 trailing a CAGR of 33.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 21.2% and 23.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 21.8% CAGR.

Global Maternal Mental Health Market - Key Trends & Drivers Summarized

Why Is Maternal Mental Health Finally Receiving the Attention It Deserves?

Maternal mental health is rapidly gaining recognition as a vital component of global public health, moving beyond its once-muted position to the forefront of healthcare conversations. Increased awareness around postpartum depression, perinatal anxiety, and mood disorders during and after pregnancy has led to growing advocacy and policy focus. For decades, maternal mental health issues were underdiagnosed and undertreated due to social stigma, limited screening protocols, and a lack of integrated care frameworks. Today, growing scientific evidence and public discourse are highlighting the profound impact maternal mental health can have not only on mothers but also on infant development, partner dynamics, and family wellbeing. The stressors of modern motherhood-ranging from economic insecurity and social isolation to medical complications and sleep deprivation-are intensifying the mental health burden among new mothers. The COVID-19 pandemic further exacerbated these challenges, with lockdowns, disrupted healthcare access, and limited support systems significantly increasing maternal distress globally. In response, governments, NGOs, and health institutions are investing in maternal mental health screening programs, educational campaigns, and early intervention strategies. Cultural narratives are also shifting, empowering women to speak openly about their struggles and seek timely care, transforming maternal mental health into a priority within broader women’s health agendas.

How Are Innovations in Digital Health Transforming Maternal Mental Healthcare Delivery?

Technology is playing an instrumental role in reshaping how maternal mental healthcare is delivered, accessed, and scaled. Digital health platforms, including mobile apps, telepsychiatry, and virtual support groups, are bridging care gaps for new and expecting mothers who may lack access to traditional mental health services. AI-powered mental health tools are being developed to monitor behavioral changes, screen for risk factors, and deliver cognitive behavioral therapy (CBT) modules tailored for postpartum and perinatal stages. Mobile-first approaches are particularly effective in rural and underserved regions, where infrastructure and healthcare personnel shortages limit access to in-person services. Wearable technology and health trackers are also emerging as supportive tools, helping monitor sleep patterns, stress levels, and hormonal fluctuations-key indicators of maternal mental health. Moreover, integrated maternal health platforms now offer mental health resources alongside obstetric tracking, creating a more holistic care experience. Virtual consultations with therapists and mental health professionals are reducing stigma and enabling discreet, flexible support for women juggling newborn care and recovery. These innovations are not only enhancing early diagnosis and intervention but also democratizing mental health care, making it more inclusive and responsive to the unique emotional landscape of motherhood.

Is the Evolving Role of Employers, Insurers, and Health Systems Driving Market Expansion?

The maternal mental health ecosystem is being reshaped by an expanding network of stakeholders beyond traditional healthcare providers. Employers are beginning to view maternal mental wellness as a critical component of workforce productivity and retention, prompting the inclusion of postpartum mental health resources in employee assistance programs (EAPs). Corporate wellness platforms now offer new-parent counseling, mindfulness tools, and flexible leave policies that acknowledge the emotional complexities of returning to work after childbirth. Insurers are also taking note-some health plans now reimburse for postpartum therapy, mental health screenings during prenatal visits, and app-based mental wellness subscriptions. Meanwhile, health systems are integrating mental health assessments into standard prenatal and postnatal care pathways, often using standardized tools like the Edinburgh Postnatal Depression Scale (EPDS) during checkups. Multidisciplinary care teams-comprising obstetricians, midwives, therapists, and pediatricians-are creating coordinated care models to identify and address mental health concerns early. Public health initiatives and donor funding are supporting pilot programs that train community health workers in maternal mental health screening, especially in low-resource settings. At the policy level, maternal mental health legislation is being introduced in several countries to ensure universal screening and improve care access. As systemic support increases, demand for scalable solutions-including digital therapeutics, support networks, and culturally adapted mental health services-is accelerating across geographies.

What Are the Core Drivers Powering the Maternal Mental Health Market’s Expansion?

The growth in the maternal mental health market is driven by several factors rooted in evolving healthcare delivery models, shifting societal norms, and technology-driven innovation. Rising awareness of the clinical and social implications of untreated maternal mental health conditions has led to increased investment in early screening and intervention protocols, particularly within maternal and child health programs. The widespread use of digital platforms is expanding access to care, especially among younger, tech-savvy mothers seeking flexible and stigma-free support options. Demographic shifts, such as delayed motherhood and higher rates of high-risk pregnancies, are contributing to increased emotional vulnerability during the perinatal period, thus fueling demand for preventive mental health services. The growing integration of behavioral health into obstetric and pediatric settings is creating structural pathways for continuous mental health monitoring from pregnancy through postpartum. Insurance reforms and employer-backed health initiatives are driving reimbursement and utilization of maternal mental health services across both public and private sectors. Additionally, the increasing availability of culturally sensitive and multilingual content is enabling better outreach among diverse populations. In low- and middle-income countries, donor-led programs and global health partnerships are scaling grassroots interventions and mental health training, expanding market potential beyond developed regions. As the maternal mental health narrative evolves from reactive treatment to proactive wellness, it is creating a sustained and diversified demand for services, technologies, and support ecosystems worldwide.

SCOPE OF STUDY:

The report analyzes the Maternal Mental Health market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Disease Indication (Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication, Other Disease Indications); Therapy (Antidepressants Therapy, Interpersonal Psychotherapy, Cognitive Behavioral Therapy, Other Therapies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Ahma & Co Postpartum Retreat
  • Anne Arundel Medical Center Maternal Mental Health
  • BetterHelp
  • COOJ Mental Health Foundation
  • Inova Perinatal Mental Health
  • Mammha
  • Maternal Mental Health Alliance
  • Maternal Mental Health Leadership Alliance
  • MPower Minds
  • MS Chellamuthu Trust & Research Foundation
  • Parivarthan Counselling, Training and Research Centre
  • Policy Center for Maternal Mental Health
  • Postpartum Support International
  • Seleni Institute
  • Tele-MANAS
  • The Live Love Laugh Foundation
  • The Motherhood Group

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Maternal Mental Health - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness Around Postpartum Depression Throws the Spotlight on Early Detection and Support Services
    • Global Push for Holistic Maternal Care Strengthens Business Case for Integrated Mental Health Screening
    • Increased Burden of Stress and Anxiety During Pregnancy Expands Addressable Market Opportunity for Preventive Interventions
    • Shift Toward Virtual Care Models Spurs Growth in Teletherapy and Digital Counseling for Expecting and New Mothers
    • Here's the Story: Social Media and Influencer Advocacy Normalize Conversations Around Maternal Mental Well-Being
    • Workforce Reentry Pressures and Parental Guilt Drive Demand for Emotional Support and Resilience Programs
    • Growing Integration of Behavioral Health in OB/GYN Settings Drives Adoption of Routine Mental Health Checkpoints
    • Here's How Mobile Health Apps and Digital Journals Empower Self-Monitoring and Early Symptom Reporting
    • Rising Incidence of Maternal Suicide and Untreated Disorders Propels Policy-Level Intervention and Care Funding
    • Cultural Shifts and Urban Isolation Accelerate Demand for Community-Based Maternal Support Networks
    • Adoption of AI-Powered Chatbots and Virtual Companions Creates Scalable, Non-Stigmatizing Mental Health Avenues
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Maternal Mental Health Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Maternal Mental Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Maternal Mental Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Maternal Mental Health by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Postpartum Depression Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Postpartum Depression Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Postpartum Depression Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Dysthymia Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Dysthymia Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Dysthymia Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pregnancy & Postpartum General Anxiety Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pregnancy & Postpartum General Anxiety Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Pregnancy & Postpartum General Anxiety Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pregnancy & Postpartum OCD Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pregnancy & Postpartum OCD Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Pregnancy & Postpartum OCD Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Birth-Related PTSD Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Birth-Related PTSD Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Birth-Related PTSD Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Antidepressants Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Antidepressants Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Antidepressants Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Interpersonal Psychotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Interpersonal Psychotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Interpersonal Psychotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Cognitive Behavioral Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Cognitive Behavioral Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Cognitive Behavioral Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • JAPAN
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • CHINA
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • EUROPE
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Maternal Mental Health by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Maternal Mental Health by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Maternal Mental Health by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • FRANCE
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • GERMANY
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Spain 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Russia 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Maternal Mental Health by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Maternal Mental Health by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Maternal Mental Health by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 122: Australia Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Australia Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Australia 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • INDIA
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 125: India Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 128: India Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: India Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: India 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 134: South Korea Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: South Korea Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: South Korea 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Asia-Pacific Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Asia-Pacific 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Maternal Mental Health by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Maternal Mental Health by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Maternal Mental Health by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Latin America 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 155: Argentina Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Argentina Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Argentina 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 161: Brazil Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Brazil Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Brazil 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 167: Mexico Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Mexico Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Mexico 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Latin America Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Latin America Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Latin America 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Maternal Mental Health by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Maternal Mental Health by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Maternal Mental Health by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Middle East 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 188: Iran Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Iran Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Iran 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 194: Israel Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Israel Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Israel 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 200: Saudi Arabia Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Saudi Arabia Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Saudi Arabia 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 206: UAE Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: UAE Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: UAE 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 212: Rest of Middle East Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Middle East Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Rest of Middle East 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030
  • AFRICA
    • Maternal Mental Health Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Maternal Mental Health by Disease Indication - Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Maternal Mental Health by Disease Indication - Percentage Breakdown of Value Sales for Postpartum Depression Disease Indication, Dysthymia Disease Indication, Pregnancy & Postpartum General Anxiety Disease Indication, Pregnancy & Postpartum OCD Disease Indication, Birth-Related PTSD Disease Indication and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 218: Africa Recent Past, Current & Future Analysis for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Africa Historic Review for Maternal Mental Health by Therapy - Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Africa 15-Year Perspective for Maternal Mental Health by Therapy - Percentage Breakdown of Value Sales for Other Therapies, Antidepressants Therapy, Interpersonal Psychotherapy and Cognitive Behavioral Therapy for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제